Navigation Links
Palos Offers New Technology in the Fight Against Breast Cancer
Date:11/1/2011

PALOS HEIGHTS, Ill., Nov. 1, 2011 /PRNewswire-USNewswire/ -- When it comes to breast cancer, a physician's ability to accurately stage a tumor and determine the best course of treatment depends on the quality of information revealed through diagnostic imaging tests. Once again, Palos Community Hospital offers patients the most advanced technology in breast cancer detection with positron emission mammography, or PEM. It is one of only two PEM scanners in the Chicagoland area.

Essentially, PEM is a specially designed positron emission tomography (PET) scanner for imaging breasts and other small body parts. For decades, PET has been a critical tool in the treatment of cancer. Just as PET uses injected radioactive isotopes to locate cancer cells throughout the entire body, PEM does the same but on a much smaller scale and with greater accuracy than breast MRI. PEM generates 12 tomographic slices per view, offering a 3-D perspective of the breast. With PEM, physicians can detect tumors as small as 2 mm, about the width of a grain of rice.

"PEM images show the location of suspicious masses, giving physicians a map upon which they can base treatment options and/or surgical plans," says Vicki McFarlane, administrative director for Imaging Services. "This technology allows doctors to better determine candidates for breast conserving surgery or lumpectomy. PEM also may be used to monitor treatments or to check for recurrence of disease."

Because PEM is a more advanced diagnostic tool, it is not recommended as a general screening test for all patients. But for women who have been diagnosed with breast cancer, PEM provides the most advanced technology available to help fight the disease.

PEM scans are available at the Palos Diagnostic Center in Tinley Park. Patients with an order may schedule a PEM by calling (708) 923-8120. The Palos Diagnostic Center located in the Alpha Med building at 17333 S. LaGrange Rd. in Tinley Park.

Palos Community Hospital's Comprehensive Breast Program combines the technological capabilities of digital mammography, ultrasound, magnetic resonance imaging and PEM with a highly skilled and compassionate staff. All members of Palos' breast health treatment team are trained in breast care and work together to plan your treatment. In fact, Palos Community Hospital is the only hospital in Chicago's southwest suburbs with three board-certified radiologists who are fellowship trained in mammography, a breast health patient navigator as well as two dedicated breast surgeons.


'/>"/>
SOURCE Palos Community Hospital
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Advancements in Technology Benefit Cardiology Patients at Palos Community Hospital
2. Steering Drivers in the Right Direction, "Healthy Vision™ With Dr. Val Jones" Radio Show Offers Information, Advice About Driving in the Dark
3. CoreLab Partners Now Offers Semi-automated ECG Solutions
4. SANYO Offers Researchers Energy-Efficient, Space-Saving Solutions for Biological Sample Preservation
5. Global Leader in Medical Technology Offers for Sale Seven Patent Portfolios Through ICAP Patent Brokerage
6. Stethocap Disposable Stethoscope Covers - a Sound Solution: ICAP Patent Brokerage Offers to Sell IP Disclosing Effective Protection for Stethoscope Heads Without Impacting Sound Transmission
7. Elsevier Offers 950 New Health Titles to Research4Life
8. Rock Creek Pharmaceuticals Offers International Shipping Options for Anatabloc™
9. In The Face of Pain® Offers New Tools and Resources to Patients, Caregivers and Healthcare Professionals Advocating for Better Pain Care
10. Promises Treatment Centers Offers Program Addressing Dramatic Rise in Prescription Pill Addiction by Teens
11. Non-Profit Offers 3 Easy Consumer Tips to Save on Prescriptions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... The Mobile X-Ray product segment is the most attractive market ... period Mobile X-Ray segment is the largest segment ... market, which is estimated to be valued at more than ... 7% over the forecast period. Mobile X-Ray segment is expected ... Mn in 2017 over 2016. The segment,s revenue in the ...
(Date:4/19/2017)... 2017 Global Prostate Cancer Therapeutics Market: ... prostate cancer therapeutics market analyzes the current and ... of prostate cancer, launch of promising emerging therapies, ... new drugs & therapeutic biological products, and high ... lesser side effects are some of the drivers ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... An April 24th article on Yahoo! ... 180 pounds with the help of a weight loss surgery. The woman, declaring “I will ... that have been left following her dramatic weight loss. Dr. Feiz & Associates notes that, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Somnoware, a leading provider ... Online(TM), which enables sleep physicians to create and edit their interpretation reports. This ... provides a familiar interface that does not require additional training to use. It ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, ... the GlycoMark test throughout the Northeast U.S. , GlycoMark is the only ... The GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic ... has joined the revolutionary endoscopic practice under Dr. Datta. Patel is a Board ... Medicine. The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is ...
(Date:4/28/2017)... Ca (PRWEB) , ... April 28, 2017 , ... ... cardiac or hERG liability could substantially improve drug safety and minimize the cost ... provided for validating ion channel inhibition using cell lines and for cardiac toxicity ...
Breaking Medicine News(10 mins):